Volume 6 Supplement 1

Fifth Dominique Dormont International Conference. Host-Pathogen Interactions in Chronic Infections

Open Access

Health care of children diagnosed HIV positive before 18 months in Chea Chumneas Hospital, Takhmao, Cambodia

  • Denisa Augustinova1,
  • Born Ban1,
  • Chhunly Kong2,
  • KimSong La1,
  • Suos Prem Prey3,
  • Mealin Kong2,
  • Sopheak Ngin4,
  • Eric Nerrienet4 and
  • Martin Bandzak1
Retrovirology20096(Suppl 1):P15

https://doi.org/10.1186/1742-4690-6-S1-P15

Published: 22 July 2009

Background

Effective health care delivery to the majority of HIV exposed infants worldwide, including those enrolled in prevention of mother-to-child transmission programs, is hampered by lack of access to an HIV diagnosis in infancy. Early testing can help HIV infected infants access treatment, provide psychosocial benefits for families of uninfected infants, and help programs for prevention of mother-to-child transmission of HIV monitor their effectiveness.

Main objective

The aim of the study was to report the impact of the early testing of HIV on the improved health care of the HIV-infected children and to describe the treatment outcomes in children (< 18 months of age).

Methods

Analysis of cumulative data gathered between April 2006 and December 2008 at Chey Chumneas Hospital including children born under PMTCT and the others attending pediatric services, which general pediatric out-patient include i) general pediatric out-patients, ii) nutrition rehabilitation centre, iii) in-patients care, iv) OI/HAART access and trained medical staff supported by NCHADS and Magna Children at Risk.

Preliminary results

During the study period, 174 HIV-exposed infants, less than 18 months, attending pediatric services were screened for HIV-1 infection. 137 (78,7%) had an undetectable HIV-1 DNA/RNA viral load confirmed on a second blood samples. 37 (21,2%) were found and confirmed HIV-1 infected, including 9 who received a PMTCT intervention. Four out of 37 HIV positive children were lost of follow up, 4 were transferred to another service, 7 died (two were already on HAART), 13 children were on OI prophylaxis only. Finally 12/37 infected children started already HAART (3TC+d4T+NVP).

Conclusion/perspectives

The virological efficacy of treatments for the 12 children on HAART is currently under evaluation and will be presented. According to the new WHO guidelines for Paediatric HIV/ART Care, all the others infected children (n = 13) will get HAART as soon as possible. The results of this study confirm that early testing is crucial to improve health care delivery to HIV-infected children in low-resource settings right now. Well adapted pediatric services are also needed for the complex follow-up of HIV infected children.

Authors’ Affiliations

(1)
Magna Children at Risk
(2)
Chey Chumneas Referral Hospital
(3)
The National Centre for HIV/AIDS Dermatology and STDs
(4)
HIV/Hepatitis Laboratory, Institute Pasteur

Copyright

© Augustinova et al; licensee BioMed Central Ltd. 2009

This article is published under license to BioMed Central Ltd.

Advertisement